血清乳脂球表皮生长因子-8在心肌缺血再灌注损伤中的表达及意义
[Abstract]:Objective: To investigate the expression of serum milk fat ball epidermal growth factor-8 (MFG-MAA) in acute myocardial infarction (AMI) patients with myocardial ischemia-reperfusion injury (MIRI) and (MFG-VEP) and hypersensitive C-reactive protein (Hs-CRP). Study on the correlation between interleukin-6 (interleukin-6, IL-6). Methods: 40 patients with ST-segment elevation myocardial infarction (STEMI) treated with PCI were treated as AMI group from January 2014 to August 2014 due to acute myocardial infarction. During the same period, the chest was not suitable for hospitalization in our hospital, and coronary angiography was performed in parallel. The results showed that 30 patients with no obvious stenosis were treated as control group. Two groups of patients were treated with PCI or coronary angiography (CAG), 24 hours after operation, 5 ml of venous blood were taken after 48 hours of operation, and then stored in -80 掳 C refrigerator after centrifugation. All patients had cardiac troponin, creatine kinase isoenzymes, BNP, liver function, renal function, blood lipid and blood glucose monitoring on the day of admission, and also recorded the type of arrhythmia that occurred after myocardial infarction related blood vessels were opened. Further tracking of adverse events during hospitalization (e.g., recurrent myocardial infarction, heart failure, cardiogenic shock, sudden cardiac death, severe arrhythmia, etc.). After the samples were collected, the levels of MFG-, Hs-CRP and IL-6 were detected by ELISA, and the levels of various factors were compared at different time points. Statistical analysis was performed with SPSS18. 0 software. Results: (1) The levels of MFG and MFG in each time point of AMI group were lower than those of control group at corresponding time point (P = 0.0003, P = 0.0006, P = 0.0002). The level of mfg-e8 in serum of AMI group increased significantly at 24 hours after operation (P = 0.0006), and the level of mfg-e8 in serum of AMI group continued to increase within 48 hours after operation (p = 0.0005, p = 0.0001). There was no significant difference in serum mfg-e8 levels after operation (p = 0.067, p = 0.059, p = 0.150). (2) The levels of hs-crp in each time point of ami group were higher than those of control group at corresponding time point (p = 0.0012, p = 0.0006, p = 0.0005). The serum hs-crp levels in the ami group increased significantly at 24 hours after operation (p = 0.0002), and the serum hs-crp level decreased significantly at 48 hours after operation (p = 0.0008), but still increased significantly before operation (p = 0.0005). There was no significant difference (p = 0.100, p = 0.350, p = 0.058) between the levels of hs-crp in serum before and after operation. (3) The level of serum IL-6 in each time point of the ami group was higher than that of the control group at the corresponding time point (p = 0.0009, p = 0.0003, p = 0.028). The serum IL-6 level in the ami group increased significantly before operation (p = 0.0002), and the serum IL-6 level continued to increase within 48 hours after operation (p = 0.0003, p = 0.0001). There was no significant difference in serum IL-6 group after operation (p = 0.055, p = 0.140, p = 0.320). (4) The level of mfg-e8 in each time point of the ami group was negatively correlated with the hs-crp level (r =-0.474, p = 0.003; r =-0.462, p = 0.00006; r =-0.474, p = 0.00008), negatively correlated with the level of il-6 (r =-0.408, p = 0.00005; r =-0.439, p = 0.00004); the level of hs-crp in each time point of the ami group was positively correlated with the il-6 level (r = 0.434, p = 0.00003; r = 0.436, p = 0.0008; r = 0.9399, p=0.001). (5) The occurrence (ra) of reperfusion arrhythmia was observed immediately after the opening of the infarct-related blood vessel (ira) in the ami group, including: slow onset, premature ventricular premature beat, atrial premature beat, ventricular fibrillation, atrioventricular block, atrial arrest, ventricular tachycardia. (6) According to whether bnp was normal at 24 hours after operation, the patients were divided into the bnp abnormal group and the bnp normal group, among which, the mfg-e8 levels in the bnp abnormal group were significantly lower than those in each time point mfg-e8 (p = 0. 003). (7) According to the occurrence of adverse events during hospitalization, the patients of AMI group were divided into adverse event group and no adverse event group, and the MFG-VEP level was significantly lower in patients with adverse events in hospital than those in the absence of adverse events (P = 0.0012). Conclusion: (1) MFG-NHL is involved in the process of MIRI in patients with AMI, and may be involved in MIRI process by inhibiting inflammatory cytokines Hs-CRP and IL-6 release. (2) MFG-MAA has a certain predictive value for the long-term prognosis of patients with acute myocardial infarction.
【学位授予单位】:济宁医学院
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R542.22
【相似文献】
相关期刊论文 前10条
1 王靓;赵殊;杜明兰;;几种常用中药对心肌缺血—再灌注损伤的防治研究[J];中国卫生产业;2014年01期
2 王曙光,徐小虎,高庆春,黄如训;急性心肌缺血再灌注对脑组织的影响[J];中国神经精神疾病杂志;2001年03期
3 刘雅,董振明;白细胞与心肌缺血再灌注损伤[J];河北医药;2001年12期
4 林函;心肌缺血再灌注损伤中线粒体的作用[J];国外医学.麻醉学与复苏分册;2002年05期
5 张英杰;血管紧张素Ⅱ受体拮抗剂在心肌缺血再灌注损伤中的作用[J];中国煤炭工业医学杂志;2002年02期
6 高国栋,韩志岩;核因子-κB与心肌缺血再灌注损伤[J];中国分子心脏病学杂志;2002年06期
7 杨阳;中医药防治心肌缺血再灌注损伤研究新进展[J];现代中西医结合杂志;2003年11期
8 杨彦玲,师养荣,李建龙,陈雅慧;心肌缺血再灌注损伤研究进展[J];心血管病学进展;2003年02期
9 李领召,张昱;中医药防治心肌缺血再灌注损伤研究进展[J];中国中医药信息杂志;2003年S1期
10 朱彬,万朝敏,郭慧玲,肖静,王正荣;心肌缺血再灌注损伤时心肌肌球蛋白ATP酶活性的改变[J];四川大学学报(医学版);2004年02期
相关会议论文 前10条
1 王彩歌;王永霞;;心肌缺血再灌注损伤研究进展[A];第二届全国中西医结合心血管病中青年论坛暨第二届黄河心血管病防治论坛资料汇编[C];2011年
2 李长岭;蒋峻;樊友启;丁芳;Wieming Fan;Ling Wei;;肿瘤坏死因子a受体1敲除对心肌缺血再灌注损伤作用的研究[A];2006年浙江省内科学学术年会、2006年浙江省老年医学学术年会论文汇编[C];2006年
3 王彩歌;王永霞;;心肌缺血再灌注损伤研究进展[A];2011年中华中医药学会心病分会学术年会暨北京中医药学会心血管病专业委员会年会论文集[C];2011年
4 陈协辉;李鹏;黄小平;王东明;陈宋明;杨泽民;陈智凡;许文敏;陈丽萍;;气体信号分子硫化氢对大鼠心肌缺血再灌注损伤的保护作用[A];中华医学会第十五次全国心血管病学大会论文汇编[C];2013年
5 李培军;;心肌缺血再灌注损伤——基础与临床[A];中华医学会第一届重症心脏全国学术大会暨第二届西湖重症医学论坛、2013年浙江省重症医学学术年会论文汇编[C];2013年
6 彭涛;徐明江;滕旭;管又飞;;AZ12417698对大鼠心肌缺血/再灌注损伤保护作用的研究[A];中国生理学会第23届全国会员代表大会暨生理学学术大会论文摘要文集[C];2010年
7 吴仪;谢中光;;心肌缺血再灌注,有关自由基的几个问题(简报)[A];第三次全国急诊医学学术会议论文摘要汇编[C];1990年
8 辛平;朱伟;李静;刘铭雅;李京波;Andrew N.Redington;魏盟;;缺血后处理联合远端缺血期处理对大鼠心肌缺血再灌注损伤保护的研究[A];中华医学会第11次心血管病学术会议论文摘要集[C];2009年
9 吴志明;董丽莉;樊冰;潘翠珍;舒先红;;斑点追踪显像技术评价心肌缺血再灌注对心肌扭转影响的实验研究[A];第十届全国超声心动图学术会议论文[C];2010年
10 袁肇凯;黄献平;曹金枝;胡志希;简亚平;;心肌缺血再灌注损伤大鼠冠状微循环改变的实验研究[A];中国微循环学会第五届中国微循环学术大会论文摘要汇编[C];2004年
相关重要报纸文章 前7条
1 陶春祥;何占德;中药单体防治心肌缺血/再灌注损伤[N];中国医药报;2004年
2 陶春祥 何占德;中医方药防治MI/R损伤研究[N];中国医药报;2004年
3 广文;让心肌重现生机[N];医药经济报;2003年
4 武开宏;心肌也能再生[N];健康报;2005年
5 ;防治急性心肌缺血再灌注损伤实验研究通过鉴定[N];中国高新技术产业导报;2001年
6 江苏省中医药研究院 李伟 沈明勤 陆晓晖;中药防治心肌缺血再灌注损伤作用机制探讨[N];中国医药报;2011年
7 ;中药可用于心脏保存[N];中国医药报;2003年
相关博士学位论文 前10条
1 姚恒臣;HMGB1对大鼠心肌缺血再灌注损伤的作用及信号传导通路[D];山东大学;2015年
2 郭小芙;内质网应激在高血压大鼠心肌缺血再灌注损伤中的作用[D];苏州大学;2015年
3 闫福曼;心肌微环境诱导间充质干细胞通道蛋白表达及丹参酮的干预作用研究[D];广州中医药大学;2009年
4 吴成;心肌缺血再灌注损伤及药物保护的实验研究[D];中国协和医科大学;1992年
5 沈波;趋化因子受体5在大鼠心肌缺血再灌注损伤中的作用及机制研究[D];武汉大学;2013年
6 徐世安;大鼠心肌缺血再灌注损伤中肿瘤坏死因子的实验研究[D];中国医科大学;2002年
7 林运灵;高迁移率族蛋白1在大鼠心肌缺血再灌注损伤中的作用及丙酮酸乙酯的疗效[D];福建医科大学;2010年
8 郭佳;脂联素对大鼠心肌缺血再灌注损伤的保护作用及机制研究—抑制内质网应激[D];山西医科大学;2013年
9 吴锦波;促红细胞生成素在大鼠心肌缺血再灌注损伤中的保护性作用研究[D];南方医科大学;2009年
10 张贵灿;腺病毒载体介导人白介素10转基因对大鼠心肌缺血再灌注损伤的影响[D];福建医科大学;2006年
相关硕士学位论文 前10条
1 袁琪;大鼠心肌缺血再灌注损伤病理机制及STVNa保护作用的蛋白质组学研究[D];华南理工大学;2015年
2 陈辉;法西多曲对大鼠心肌缺血再灌注损伤的保护作用研究[D];湖北科技学院;2015年
3 杜勤;咖啡酸对硝基苯乙酯抗大鼠MI/RI作用的蛋白印迹分析[D];西南大学;2015年
4 张宗雷;血清乳脂球表皮生长因子-8在心肌缺血再灌注损伤中的表达及意义[D];济宁医学院;2015年
5 李海勋;PR39与ADM共载体rAAV分泌表达后对心肌缺血再灌注损伤的保护性研究[D];第四军医大学;2015年
6 黄益素;抑制核因子κB对缺血再灌注大鼠心肌保护作用的研究[D];中国医科大学;2003年
7 冷立娟;重组水蛭素对心肌缺血再灌注损伤的保护作用及其作用机制的实验研究[D];第四军医大学;2004年
8 李沛鸿;抑制炎性反应双通路对心肌缺血再灌注损伤预后的影响及机制研究[D];兰州大学;2013年
9 孙辉;重组人肿瘤坏死因子受体抗体融合蛋白联合缺血后适应减轻大鼠心肌缺血再灌注损伤[D];福建医科大学;2010年
10 王阳;腺苷对大鼠心肌缺血再灌注损伤保护作用的实验研究[D];中国医科大学;2005年
,本文编号:2307024
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2307024.html